Reference is made to the stock exchange announcements from DiaGenic
regarding the ongoing Rights Issue.
Today Ruben Ekbråten subscribed for 250,000 shares at NOK 0.50 per share
in the Rights Issue. After completion of the Rights Issue, Ekbråten will
increase his holding in the Company from 10,120 shares and 124,021
subscription rights, to minimum 134,141 shares and maximum 260,120
shares, subject to the results of the allocation of shares in the Rights
Issue.
The completion of the subscriptions in the Rights Issue will be
conditional upon registration of the increased share capital of the
Company in the Norwegian Register of Business Enterprises.